Key result
Combined transcutaneous auricular vagus stimulation (taVNS) with 0.1Hz slow breathing enhances insomnia treatment efficacy.
Why the study?
Primary treatments for insomnia disorder, including cognitive-behavioral therapy and pharmacotherapy, are limited by compliance issues, cost, side effects, and variable individual efficacy.
Does combined transcutaneous auricular vagus stimulation (taVNS) with 0.1Hz slow breathing improve insomnia treatment efficacy in patients with insomnia disorder?
Does combined transcutaneous auricular vagus stimulation (taVNS) with 0.1Hz slow breathing improve insomnia treatment efficacy in patients with insomnia disorder?
Combined transcutaneous auricular vagus stimulation with 0.1Hz slow breathing is being investigated as a novel neuromodulation technique for insomnia disorder.
Hypothesis-generating for brain stimulation in insomnia; prospective trials needed before clinical adoption.
Insomnia disorder (ID) afflicts as much as a third of the global adult populace, constituting a substantial public health challenge that profoundly affects individuals' overall well-being, quality of life, and the socioeconomic framework [1]. While cognitive-behavioral therapy for insomnia (CBT-I) and pharmacotherapy serve as the primary treatment approaches, they are beset by issues of compliance, cost, and side effects, and their efficacy appears to vary among individuals. Consequently, various neuromodulation techniques endeavor to offer innovative therapeutic alternatives [2].
No takes yet. Share an insight, caveat, or question.
Tian et al. (2023) studied Insomnia disorder. Combined transcutaneous auricular vagus stimulation (taVNS) with 0.1Hz slow breathing was evaluated. Combined transcutaneous auricular vagus stimulation (taVNS) with 0.1Hz slow breathing enhances insomnia treatment efficacy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: